Literature DB >> 24627582

Overgrowth of the indigenous gut microbiome and irritable bowel syndrome.

William Bye1, Naveed Ishaq1, Terry D Bolin1, Vic M Duncombe1, Stephen M Riordan1.   

Abstract

Culture-independent molecular techniques have demonstrated that the majority of the gut microbiota is uncultivable. Application of these molecular techniques to more accurately identify the indigenous gut microbiome has moved with great pace over recent years, leading to a substantial increase in understanding of gut microbial communities in both health and a number of disorders, including irritable bowel syndrome (IBS). Use of culture-independent molecular techniques already employed to characterise faecal and, to a lesser extent, colonic mucosal microbial populations in IBS, without reliance on insensitive, traditional microbiological culture techniques, has the potential to more accurately determine microbial composition in the small intestine of patients with this disorder, at least that occurring proximally and within reach of sampling. Current data concerning culture-based and culture-independent analyses of the small intestinal microbiome in IBS are considered here.

Entities:  

Keywords:  Gut microbiome; Irritable bowel syndrome; Small intestinal bacterial overgrowth

Mesh:

Substances:

Year:  2014        PMID: 24627582      PMCID: PMC3949255          DOI: 10.3748/wjg.v20.i10.2449

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Irritable bowel syndrome and small intestinal bacterial overgrowth.

Authors:  David Yamini; Mark Pimentel
Journal:  J Clin Gastroenterol       Date:  2010 Nov-Dec       Impact factor: 3.062

2.  Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

Authors:  Derek Yu; Frank Cheeseman; Stephen Vanner
Journal:  Gut       Date:  2010-11-26       Impact factor: 23.059

3.  Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

Authors:  Erja Malinen; Lotta Krogius-Kurikka; Anna Lyra; Janne Nikkilä; Anne Jääskeläinen; Teemu Rinttilä; Terttu Vilpponen-Salmela; Atte Johannes von Wright; Airi Palva
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

4.  Small intestinal bacterial overgrowth in the symptomatic elderly.

Authors:  S M Riordan; C J McIver; D Wakefield; T D Bolin; V M Duncombe; M C Thomas
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

5.  Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

Authors:  R S Choung; K C Ruff; A Malhotra; L Herrick; G R Locke; W S Harmsen; A R Zinsmeister; N J Talley; Y A Saito
Journal:  Aliment Pharmacol Ther       Date:  2011-03-13       Impact factor: 8.171

Review 6.  Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Alexander C Ford; Brennan M R Spiegel; Nicholas J Talley; Paul Moayyedi
Journal:  Clin Gastroenterol Hepatol       Date:  2009-08-12       Impact factor: 11.382

Review 7.  Gastrointestinal motility disorders and bacterial overgrowth.

Authors:  E Husebye
Journal:  J Intern Med       Date:  1995-04       Impact factor: 8.989

8.  Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients.

Authors:  Angèle P M Kerckhoffs; Melvin Samsom; Michel E van der Rest; Joris de Vogel; Jan Knol; Kaouther Ben-Amor; Louis M A Akkermans
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 9.  Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.

Authors:  Leonilde Bonfrate; Jan Tack; Ignazio Grattagliano; Rosario Cuomo; Piero Portincasa
Journal:  Scand J Gastroenterol       Date:  2013-09       Impact factor: 2.423

10.  Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Authors:  Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal
Journal:  Gut       Date:  2012-06-22       Impact factor: 23.059

View more
  6 in total

Review 1.  Application of metagenomics in the human gut microbiome.

Authors:  Wei-Lin Wang; Shao-Yan Xu; Zhi-Gang Ren; Liang Tao; Jian-Wen Jiang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

Review 3.  Gut microbiota and allogeneic transplantation.

Authors:  Weilin Wang; Shaoyan Xu; Zhigang Ren; Jianwen Jiang; Shusen Zheng
Journal:  J Transl Med       Date:  2015-08-23       Impact factor: 5.531

4.  Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.

Authors:  Robyn Nagel; Rebecca J Traub; Richard J N Allcock; Marcella M S Kwan; Helle Bielefeldt-Ohmann
Journal:  Microbiome       Date:  2016-08-31       Impact factor: 14.650

5.  Case-Control Research Study of Auto-Brewery Syndrome.

Authors:  Barbara Jean Cordell; Anup Kanodia; Gregory K Miller
Journal:  Glob Adv Health Med       Date:  2019-04-18

6.  Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics.

Authors:  Huihui Guan; Yanni Pu; Chenglin Liu; Tao Lou; Shishang Tan; Mengmeng Kong; Zhonghan Sun; Zhendong Mei; Qibin Qi; Zhexue Quan; Guoping Zhao; Yan Zheng
Journal:  mSphere       Date:  2021-09-15       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.